Within the last quarter, CARISMA Therapeutics (NASDAQ:CARM) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat…
September 1, 8:34 AM
Group 2 data available to date support primary safety and feasibility endpoints of single-day bolus dosing of CT-0508 New translational analyses combining group 1 & group 2 continue to support CAR-M mechanism
Why Siyata Mobile Shares Are Trading Lower By 21%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session
July 11, 1:26 PM
Gainers CytoMed Therapeutics Limited (NASDAQ: GDTC) shares climbed 129.5% to $8.01 after gaining 9% on Monday.
Carisma Therapeutics Announces First Patient Dosed In Phase 1 Study of CT-0508 In Combination With KEYTRUDA In Patients With HER2 Overexpressing Solid Tumors
June 28, 8:31 AM
Study is designed to evaluate the potential for a synergistic effect of CAR-M therapy in combination with KEYTRUDA® PHILADELPHIA, June 28, 2023 /PRNewswire/ -- Carisma Therapeutics
June 22, 10:58 AM
U.S. stocks traded mixed, with the Dow Jones dropping around 50 points on Thursday. Here are some big stocks recording gains in today’s session.
Why Couchbase Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session
June 7, 2:02 PM
Gainers Mobiquity Technologies, Inc. (NASDAQ: MOBQ) shares gained 124% to $0.3325. Mobiquity Technologies launched ElecAlytics, an AI-Powered analytics suite added to its ElecTech platform for political campaigns.
June 7, 1:31 PM
Gainers Avalo Therapeutics (NASDAQ:AVTX) shares rose 17.3% to $3.53 during Wednesday’s regular session. The company’s market cap stands…